LADONNA BOWLING: Open Payments
NPI 1093845455 · BASTIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 37 payments from 14 companies in 2025. Trend: 2023 $644 · 2024 $853 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $179 |
| ABBVIE INC. | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Exact Sciences Corporation | 3 | $67 |
| PFIZER INC. | 3 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Dexcom, Inc. | 1 | $38 |
| Averitas Pharma Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: Ozempic, VRAYLAR, Cologuard Collection Kit, NURTEC ODT, FANAPT, XIFAXAN, Dexcom G6 Transmitter, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
